drugset / Trial / NCT01685684

Oxycodone DETERx™ Versus Placebo in Chronic Low Back Pain (CLBP)

NCT01685684

Phase 3 Completed 740 enrolled Collegium Pharmaceutical, Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the analgesic efficacy of Oxycodone DETERx compared with placebo in opioid-experienced and opioid-naive subjects with moderate-to-severe chronic low back pain requiring around-the-clock opioid analgesia for an extended period of time.

Timeline

Start
2012-08
Primary completion
2014-06
Completion
2014-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone Other / unclassified 40 mg
Subject Oxycodone Other / unclassified 160 mg

Indications